Naringerin as candidate drug against SARS-CoV-2: The role for TPC2 genomic variants in COVID-19

Detalles Bibliográficos
Autores principales: Di Maria, Emilio, Martini, Paolo, Gennarelli, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834538/
https://www.ncbi.nlm.nih.gov/pubmed/33359911
http://dx.doi.org/10.1016/j.phrs.2020.105402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834538/
https://www.ncbi.nlm.nih.gov/pubmed/33359911
http://dx.doi.org/10.1016/j.phrs.2020.105402

Ejemplares similares